Marken Offers First Hybrid Service from Brazil to USA

Approval by ANVISA Paves the Way for use of UPS Flight from Viracopos Airport

Research Triangle Park, NC, August 21, 2018 - Marken announced today that Brazil’s ANVISA has approved shipments of biological samples from Sao Paulo’s Viracopos airport to the United States using the UPS airline. The pilot program approved by the Brazilian authorities will allow biologic samples to depart from a second Sao Paulo airport to the US, thus allowing Marken to take advantage of an existing UPS flight to any US city. This additional flexibility allows Marken the ability to offer the fastest transit times and best value when compared to other couriers.

The hybrid logistics service leverages the UPS network with Marken’s clinical expertise and benefits Brazil-based clinical investigators by offering a single provider for all shipments. Marken will manage all aspects of the shipment including all investigator orders, export documentation and shipment status updates for full end-to-end visibility.

The new hybrid service extends the latest pick up times for 21 Brazilian cities by up to 5 hours, allowing investigators more time to prepare and package the sample. The use of the UPS aircraft also reduces reliance on commercial airlines, which can offload biologic cargo from time to time leading to shipment delays.

Marken has gradually increased its staff in Brazil due to the continued strong demand from cities in Brazil which are an important source of patients for clinical trials. Additionally, Marken has deployed members of its Mexico operations team to assist with the new service from Brazil, given the success of a similar hybrid service from Mexico City launched a year ago.

Wes Wheeler, Chief Executive Officer, commented on the news: “Brazil becomes the latest country from which we can offer a hybrid transport option to the United States. The new option, which allows use of a second Sao Paulo - based airport at Viracopos provides maximum flexibility for our clients. We can offer later pick-up times, earlier US delivery times and reduced paperwork for investigators in many Brazilian cities. We are the only clinical courier who can offer this level of flexibility and value. We will continue to develop hybrid options for many other cities throughout the world” 


CONTACT: Christine Noble, info@marken.com, +1 919 474 6890, www.marken.com

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.